Current and future pharmacological therapies for managing cirrhosis and its complications

• 作 者: David Kockerling Rooshi Nathwa
• 机 构: LiverUnit/DivisionofIntegrativeSystemsMedicineandDigestiveDisease
• 出 处: 世界胃肠病学杂志:英文版
• 发表日期: 2019年8期
• 关键词: CIRRHOSIS BETA-BLOCKERS RIFAXIMIN DIURETICS STATINS Proton pump inhibitors Pharm
• 基金项目: The Division of Integrative Systems Medicine and Digestive Disease at Imperial College London receives financial support from the National Institute for Health Research(NIHR)Imperial Biomedical Resear

Due to the restrictions of liver transplantation,complication-guided pharmacological therapy has become the mainstay of long-term management of cirrhosis.This article aims to provide a complete overview of pharmacotherapy options that may be commenced in